Disorders Involving Calcium, Phosphorus, and Magnesium

Por Moe, Sharon M.
Publicado em 2008

ASN Presidential Address 2014: Moving Past Nephrology’s Midlife Crisis

Por Moe, Sharon M.
Publicado no J Am Soc Nephrol (2015)

Calcium as a Cardiovascular Toxin in CKD-MBD

Por Moe, Sharon M.
Publicado no Bone (2016)

Improving Global Outcomes in Mineral and Bone Disorders

Por Moe, Sharon M., Drüeke, Tilman
Publicado em 2008

What have we learned about CKD-MBD From the EVOLVE and PRIMO trials?

Por Moe, Sharon M., Thadhani, Ravi
Publicado em 2013

The Case for Routine Parathyroid Hormone Monitoring

Por Sprague, Stuart M., Moe, Sharon M.
Publicado em 2013

Recent Advances in the Non-invasive Diagnosis of Renal Osteodystrophy

Por Moorthi, Ranjani N, Moe, Sharon M
Publicado em 2013

Vascular Calcification: Pathophysiology and Risk Factors

Por Chen, Neal X., Moe, Sharon M.
Publicado em 2012

CKD–Mineral and Bone Disorder: Core Curriculum 2011

Por Moorthi, Ranjani N, Moe, Sharon M
Publicado em 2011

Fractures in Patients with CKD: Time for Action

Por Moe, Sharon M., Nickolas, Thomas L.
Publicado no Clin J Am Soc Nephrol (2016)

Direct Effects of Phosphate on Vascular Cell Function

Por Lau, Wei Ling, Pai, Ashwini, Moe, Sharon M., Giachelli, Cecilia M.
Publicado em 2011

Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium

Por Reilly, Austin M., Gray, Amie K., Moe, Sharon M., Ichikawa, Shoji
Publicado em 2014

Annexin-Mediated Matrix Vesicle Calcification in Vascular Smooth Muscle Cells

Por Chen, Neal X, O'Neill, Kalisha D, Chen, Xianming, Moe, Sharon M
Publicado em 2008

Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment

Por Allen, Matthew R., Chen, Neal X., Gattone, Vincent H., Moe, Sharon M.
Publicado em 2013

Effects of Switching from Efavirenz to Raltegravir on Endothelial Function, Bone Mineral Metabolism, Inflammation, and Renal Function: A Randomized, Controlled Trial

Por Gupta, Samir K., Mi, Deming, Moe, Sharon M., Dubé, Michael P., Liu, Ziyue
Publicado em 2013

Association of Hepatitis C Virus Infection With Prevalence and Development of Kidney Disease

Por Moe, Sharon M., Pampalone, AJ, Ofner, Susan, Rosenman, Marc, Teal, Evgenia, Hui, Siu L.
Publicado em 2008

A Randomized Trial of Cholecalciferol versus Doxercalciferol for Lowering Parathyroid Hormone in Chronic Kidney Disease

Por Moe, Sharon M., Saifullah, Akber, LaClair, Robert E., Usman, Sohail A., Yu, Zhangsheng
Publicado em 2010

Hepatitis C Increases the Risk of Progression of Chronic Kidney Disease in Patients with Glomerulonephritis

Por Noureddine, Lama A., Usman, Sohail A., Yu, Zhangsheng, Moorthi, Ranjani N., Moe, Sharon M.
Publicado em 2010

RhoA/Rho kinase (ROCK) alters fetuin-A uptake and regulates calcification in bovine vascular smooth muscle cells (BVSMC)

Por Chen, Neal X., Chen, Xianming, O'Neill, Kalisha D., Atkinson, Simon J., Moe, Sharon M.
Publicado em 2010

Changes in skeletal collagen crosslinks and matrix hydration in high and low turnover chronic kidney disease

Por Allen, Matthew R., Newman, Christopher L., Chen, Neal, Granke, Mathilde, Nyman, Jeffry S., Moe, Sharon M.
Publicado no Osteoporos Int (2014)